Finance

Lists
5WK0:FRA
Aligos Therapeutics Inc
€4.64
-1.06%
(-0.050) 1D
Oct 8, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 5WK0...
Open
€4.64
High
€4.64
Low
€4.64
Mkt. cap
33.16M
Avg. vol.
0.00
Volume
0.00
52-wk high
€11.10
52-wk low
€3.50
No. of employees
82
Open
€4.64
High
€4.64
Low
€4.64
Mkt. cap
33.16M
Avg. vol.
0.00
Volume
0.00
52-wk high
€11.10
52-wk low
€3.50
No. of employees
82
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
13 minutes ago
Gold rises more than 1%, Fed outlook in focus
Action Forex
Action Forex
·
1 hour ago
S&P 500 Wave Analysis
About Aligos Therapeutics Inc
CEO-
Employees82
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitealigos.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
741.00K
169.00K
2.83M
27.78M
Cost of goods sold
23.94M
17.04M
23.35M
24.05M
Cost of revenue
23.94M
17.04M
23.35M
24.05M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.16M
4.94M
6.41M
5.62M
Operating expense
5.16M
4.94M
6.41M
5.62M
Total operating expenses
29.10M
21.98M
29.76M
29.67M
Operating income
-28.36M
-21.81M
-26.93M
-1.89M
Other non operating income
-3.50M
1.22M
4.07M
2.95M
EBT including unusual items
-31.48M
-19.85M
-22.72M
1.31M
EBT excluding unusual items
-31.48M
-19.85M
-22.72M
1.31M
Income tax expense
56.00K
30.00K
317.00K
2.81M
Effective tax rate
-0.18%
-0.15%
-1.40%
215.07%
Other operating expenses
-
-
-
-
Net income
-31.54M
-19.88M
-23.04M
-1.50M
Net profit margin
-4,256.01%
-11,763.91%
-814.13%
-5.41%
Earnings per share
-3.04
-1.91
-2.21
-0.14
Interest and investment income
378.00K
548.00K
140.00K
246.00K
Interest expense
-
-
-
-
Net interest expenses
378.00K
548.00K
140.00K
246.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.14M
-21.56M
-26.58M
-1.64M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps